Skip to main content

Human pIgR Antibody

R&D Systems, part of Bio-Techne | Catalog # MAB2717

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
MAB2717
MAB2717-SP

Key Product Details

Species Reactivity

Validated:

Human

Cited:

Human

Applications

Validated:

Simple Western, Western Blot

Cited:

Western Blot

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG3 Clone # 825724

Product Specifications

Immunogen

Mouse myeloma cell line NS0-derived recombinant human pIgR
Lys19-Arg638
Accession # CAA51532

Specificity

Detects human pIgR in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant mouse pIgR is observed.

Clonality

Monoclonal

Host

Mouse

Isotype

IgG3

Scientific Data Images for Human pIgR Antibody

Detection of Human pIgR antibody by Western Blot.

Detection of Human pIgR by Western Blot.

Western blot shows lysates of human stomach tissue. PVDF membrane was probed with 0.25 µg/mL of Mouse Anti-Human pIgR Monoclonal Antibody (Catalog # MAB2717) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # HAF018). A specific band was detected for pIgR at approximately 85-100 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.
Detection of Human pIgR antibody by Simple WesternTM.

Detection of Human pIgR by Simple WesternTM.

Simple Western lane view shows lysates of human stomach tissue, loaded at 1 mg/mL. A specific band was detected for pIgR at approximately 110-150 kDa (as indicated) using 2.5 µg/mL of Mouse Anti-Human pIgR Monoclonal Antibody (Catalog # MAB2717). This experiment was conducted under reducing conditions and using the 12-230 kDa separation system.

Applications for Human pIgR Antibody

Application
Recommended Usage

Simple Western

2.5 µg/mL
Sample: Human stomach tissue

Western Blot

0.25 µg/mL
Sample: Human stomach tissue

Formulation, Preparation, and Storage

Purification

Protein A or G purified from hybridoma culture supernatant

Reconstitution

Sterile PBS to a final concentration of 0.5 mg/mL. For liquid material, refer to CoA for concentration.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: pIgR

The human polymeric immunoglobulin receptor (pIgR; also known as membrane secretory component) is an approximately 100 kDa type I transmembrane glycoprotein that is synthesized as a 764 amino acid (aa) precursor. It includes a signal sequence (aa 1-18), an extracellular region (aa 19-638), a transmembrane segment (aa 639-661), and a cytoplasmic domain (aa 662-764) (1-3). The extracellular region consists of five Ig-like domains and a sixth non-Ig domain that connects to the membrane region. pIgR is expressed on secretory epithelial cells of exocrine tissues. Immunoglobulin isotypes consist of two heavy (H) and two light (L) chains. For IgA and IgM, this H2L2 monomer can form larger polymers through association with a joining chain (J chain). The Fc regions of IgA and IgM have a carboxy-terminal extension called a secretory tailpiece that binds the J chain (4). pIgR functions as a carrier that transports IgA and IgM across epithelium (5). On the basolateral surface of epithelial cells, the receptor initially binds non-covalently to IgA via a docking site on the J chain. This initiates a rearrangement in which a disulfide bond forms between pIgR and an IgA heavy chain (2). The complexes are then internalized and transcytosed to the apical surface. A soluble covalent complex called secretory IgA (SIgA) is now generated by proteolytic cleavage of the sixth extracellular domain of pIgR and released into the lumen (6). This IgA-bound and proteolytically generated pIgR fragment is referred to as secretory component (SC). Notably, human pIgR transcytoses constitutively, with or without ligand, creating both bound and free, 78 kDa SC following cleavage (3). The extracellular region of pIgR shares 64%, 65%, and 70% aa sequence identity with the equivalent region of rat, mouse and porcine pIgR, respectively. The receptor component of the complex anchors the SIgA molecule to mucous (7). SIgA is a crucial component of the mucosal immune system serving to protect the large expanse of mucous membranes that form a barrier between the interior of the body and the external environment (8).

References

  1. Krajci, P. et al. (1989) Biochem. Biophys. Res. Commun. 158:783.
  2. Piskurich, J. et al. (1995) J. Immunol. 154:1735.
  3. Brandtzaeg, P. and F-E. Johansen (2001) Trends Immunol. 22:545.
  4. Braathen, R. et al. (2002) J. Biol. Chem. 277:42755.
  5. Ben-Hur, H. et al. (2004) Int. J. Mol. Med. 14:35.
  6. Asano, M. et al. (2004) Immunology 112:583.
  7. Phalipon, A. and B. Corthesy (2003) Trends Immunol. 24:55.
  8. Uren, T. et al. (2003) J. Immunol. 170:2531.

Long Name

Polymeric Immunoglobulin Receptor

Alternate Names

FLJ22667, hepatocellular carcinoma associated protein TB6, Hepatocellular carcinoma-associated protein TB6, MGC125361, MGC125362, PIgR, Poly-Ig receptor, polymeric immunoglobulin receptor

Entrez Gene IDs

5284 (Human); 18703 (Mouse)

Gene Symbol

PIGR

UniProt

Additional pIgR Products

Product Documents for Human pIgR Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Human pIgR Antibody

For research use only

Loading...
Loading...
Loading...
Loading...